A subgroup analysis according to breast cancer subtype showed that high SPARC expression was independently associated with low pCR rate, only in the HER2 subtype (OR: 0.15; 95% CI [0.02–0.77], p = 3.3E−02) (Figure 4B). This evidence concerns the gene ERBB2 and breast carcinoma.